Vulinacimab (Anti-VEGFR2 / KDR / CD309)
Product Specifications
CAS Number
2250342-36-8
Synonyms
HLX-06
Additionnal Information
Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740050-100 1x 100 µL
IgA Secretory Component (SC05), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040026-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740689-500 1x 500 µL
Cytokeratin 8 (K8.8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880914-100 1x 100 µL
NGFR (Nerve Growth Factor Receptor) (NGFR5 + NTR/912), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details